LAB vs RUN · rev $174.4M vs P/E 6.0, rev $2.04B
Standard Biotools Inc (LAB) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
LAB currently screens at market cap $317.1M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the LAB and RUN stock pages for the full models.
Not investment advice.